Filing Details

Accession Number:
0001062993-25-011241
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-09 16:34:26
Reporting Period:
2025-06-05
Filing Date:
2025-06-09
Accepted Time:
2025-06-09 16:34:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861113 Daniel Niedzwiecki C/O Lantheus Holdings, Inc.
201 Burlington Road, South Building
Bedford MA 01730
See Remarks No Yes No No
Transaction Summary
Sold: 6,000 shares Avg. Price: $79.65 Total Value: $477,900.00
Number of Shares After Transactions: 93,057 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-05 6,000 $79.65 93,057 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.